YOON&YANG
Young Sun Cho Partner
조영선 변호사.jpg
  • TEL 82 2 6003 7518
  • FAX 82 2 6003 7832
  • E-MAIL
Young Sun Cho is a partner at Yoon & Yang LLC. His main practice areas include the healthcare industry, domestic investment and M&A of foreign corporations, and foreign direct investment.
Mr. Cho has extensive experience in assisting clients, both domestic and abroad, with legal advice, foreign direct investment, inbound investment, joint venture and M&A in a wide breadth of healthcare industries, including pharmaceuticals, medical equipment, and food. He is admitted to practice in both Korea and New York.

Experience

  • 2008-present Yoon & Yang LLC
  • 2011-present Member, International Committee, Korea Bar Association
  • 2010-present Legal Advisor, Committee for International Investment Disputes, Ministry of Justice
  • 2004-05 Paul, Weiss, Rifkind, Wharton & Garrison (New York)
  • 2000-08 Yulchon LLC
  • 1997-00 Judge Advocate, Republic of Korea Navy

Education

  • 2004 University of Pennsylvania Law School, LL.M.
  • 1998 Seoul National University Graduate School, Department of Law (coursework completed)
  • 1997 Judicial Research and Training Institute
  • 1994 Seoul National University College of Law, LL.B.

Representative Matters

[Healthcare Industry]
  • Advised a major pharmaceutical company on the registration on the list of products eligible for health insurance coverage, pricing, and registration on the Green List of an orphan drug
  • Advised a domestic biopharmaceutical company on the registration on the list of products eligible for health insurance coverage, and pricing of stem cell treatment drugs
  • Advised and represented a major multinational pharmaceutical company on the drug-approval patent linkage system
  • Advised a major domestic pharmaceutical company on the acquisition of a Europe-based pharmaceutical company
  • Advised a major multinational pharmaceutical company on a global M&A of a specific pharmaceutical business unit
  • Advised and represented a multinational food company on domestic regulations
  • Advised a multinational food company on the launching of an ice cream business
  • Advised and represented a multinational medical waste disposal company on domestic regulations
  • Advised a major domestic bakery on an overseas market entry
  • Advised on the establishment of Korea’s first ever fund specific to the pharmaceutical industry (Global Pharmaceutical Fund), which the Ministry of Health and Welfare and the Korea Finance Corporation invested in for the purpose of supporting an overseas market entry of the pharmaceutical industry
  • Advised a global pharmaceutical fund and a major domestic pharmaceutical company on the investment of shares in a United States-based biopharmaceutical company
  • Advised a major multinational medical equipment company on the legal issues of the Medical Devices Act if the permissions of an overseas medical equipment manufacturer change as a result of a transfer of business
  • Represented a multinational corneal bank to provide various legal advice, including a legal consultation on the establishment of a corneal bank in Korea

[Inbound Investment and Foreign Direct Investment]
  • Advised and represented a major domestic LED company on the establishment of a joint venture in China and Vietnam
  • Advised and represented a major coffee company on the entry into the Singaporean market
  • Advised and represented a major domestic franchise company on the entry into the Indonesian market
  • Advised and represented a major online game company on the establishment of an online game joint venture corporation in China
  • Advised and represented Daewoo International on the investment in a nickel mine in Madagascar
  • Represented a major defense company on the purchase of military goods of the Defense Acquisition Program Administration
  • Advised and represented a major domestic furniture company on an arbitration case before the United States AAA related to an overseas investment
  • Advised and represented a domestic IT company on the acquisition of a Japanese IT company
  • Advised and represented the Korea Water Resources Corporation on the investment in the nuclear plant development project by Areva (France)
  • Advised and represented a Singaporean state-run fund (Mapletree Investments) on the acquisition of a domestic logistics company
  • Advised and represented Lotte E&C regarding the Pangyo Alpha Dome City Project
  • Advised and represented the National Pension Service on the acquisition of Sony Center located in Berlin (Germany)
  • Advised and represented a major domestic securities firm regarding a high-rise residential building development project in Malaysia
  • Advised a major overseas investment bank regarding the acquisition of a major office building at the city center of Seoul

Awards

  • Leading Individual, Real estate, Chambers and Partners Asia-Pacific (2014)
  • Leading Lawyer, Real estate, M&A, asialaw (2012, 2013)

Publications

  • Overview and Implications of the Drug Patent-Approval Linkage System in South Korean Regulation (Co-Author), Korea Chapter, Practical Law Company (PLC) Multi-jurisdictional guide: Life Science, 2014
  • Latest Legislative Trends regarding Patent-Pharmaceutical Product Approval Linkage, KGCCI, 2015

Insights